A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy
Open Access
- 10 January 2026
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111147
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (F31NS139574)
- National Institute of Neurological Disorders and Stroke (R01NS117176)
- National Institute of Neurological Disorders and Stroke (R01NS105789)
- National Institute of Neurological Disorders and Stroke (R21NS145426)
This publication has 79 references indexed in Scilit:
- Inhibiting SNX14 Alleviates Epileptic Seizures by Regulating GluA2 Degradation via the Lysosomal PathwayMolecular Neurobiology, 2025
- ER‐to‐lysosome‐associated degradation in a nutshell: mammalian, yeast, and plant ER‐phagy as induced by misfolded proteinsFEBS Letters, 2023
- Reticulon-3 Promotes Endosome Maturation at ER Membrane Contact SitesDevelopmental Cell, 2021
- De novoGRINvariants in NMDA receptor M2 channel pore‐forming loop are associated with neurological diseasesHuman Mutation, 2019
- Mechanistic insights into ER-associated protein degradationCurrent Opinion in Cell Biology, 2018
- De novo mutations and rare variants occurring in NMDA receptorsCurrent Opinion in Physiology, 2017
- Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding DomainsThe American Journal of Human Genetics, 2016
- Specialization of biosynthetic membrane trafficking for neuronal form and functionCurrent Opinion in Neurobiology, 2016
- NMDA receptor subunit mutations in neurodevelopmental disordersCurrent Opinion in Pharmacology, 2015
- Differential expression of five N‐methyl‐D‐aspartate receptor subunit mRNAs in the cerebellum of developing and adult ratsJournal of Comparative Neurology, 1994